Alivus Life Sciences (NSE:ALIVUS) Liabilities-to-Assets : (As of Jun. 2026)

Alivus Life Sciences  (NSE:ALIVUS) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Alivus Life Sciences Liabilities-to-Assets Related Terms

The historical data trend for Alivus Life Sciences's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alivus Life Sciences Liabilities-to-Assets Chart

Alivus Life Sciences Annual Data
	Trend	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
Liabilities-to-Assets		Get a 7-Day Free Trial				0.17	0.21	0.18	0.18	0.17

Alivus Life Sciences Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Liabilities-to-Assets	Get a 7-Day Free Trial															-	0.17	-	0.17	-

NSE:ALIVUS vs ZTS: Liabilities-to-Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alivus Life Sciences Liabilities-to-Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's Liabilities-to-Assets falls into.

Alivus Life Sciences Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Alivus Life Sciences's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2026 is calculated as:

Alivus Life Sciences's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alivus Life Sciences Business Description